MOVING LIFE SCIENCE INNOVATIONS

FROM DISCOVERY TO DEVELOPMENT TO DELIVERY

OUR VISION OF THE FUTURE: Arizona is a top-ten life science state.

OUR MISSION: AZBio supports the needs of Arizona’s growing life science ecosystem.

OUR MEMBERS: AZBio Members make an impact. They discover, develop and deliver health innovations including medicines, medical devices, diagnostics, and a wide range of health technologies. Our members also include economic development partners, educators, investors, leading business and philanthropic organizations, and patient advocacy organizations. AZBio Members employ over 365,000 Arizonans who are working together to make life better for people in Arizona and around the world.

Our industry sector generated over $43.64 billion in Economic Impact in 2023.

That's up over 88% from 2016 and growing at a Compound Annual Growth Rate of 9.5%.

Arizona’s bioscience industry (not including our hospitals) employed 40,399 in 2023 across 3,652 state business establishments, representing a rapid 24.6 percent increase in employment since 2019 and placing the state among the leaders in employment growth. The average wage in the bioscience industry was $102,161—53 percent higher than the state’s private sector average. View More of Arizona's Bioscience Industry Data

A key component in Arizona’s life science ecosystem, the Arizona Bioindustry Association (AZBio) is the only statewide organization exclusively focused on growing Arizona’s bioscience industry.

AZBio Member Organizations in the fields of business, research and education, health care delivery, economic development, government, and other professions involved in the biosciences are the key drivers of the growth of Arizona's life science sector. As the unified voice of our industry in Arizona, AZBio strives to make Arizona a place where bioscience organizations can grow and succeed.

AZBio works nationally and globally with the Advanced Medical Technology Association (AdvaMed), the Biotechnology Innovation Organization (BIO), the Medical Device Manufacturers Association (MDMA), the Pharmaceutical Research and Manufacturers of America (PhRMA), and leading patient advocacy organizations.

Through these relationships, AZBio has access to information, contacts, resources, cost saving programs, and the global bioscience and medtech community.

Rare Disease Day 2026 – AZBio Community Speaks Up for Patients

Each February 28th, the world recognizes the needs of patients living with rare diseases on Rare Disease Day. From meetings at our nation’s capitol to podcasts highlighting work being done here in Arizona, an upcoming events at the State Capitol, and at Voice of the Patient during AZ Tech Week that amplifies the voices of […]

AZBio Member Spotlight – Reference Medicine

Based in Arizona, Reference Medicine is redefining how oncology research teams access one of the most critical resources in healthcare innovation: high-quality, clinically annotated human biospecimens. This Phoenix-based biotech company is focused on solving one of the most persistent bottlenecks in cancer research and diagnostics.

Leading Heart Transplant Centers Convene in Houston for Picard Medical/ SynCardia’s Total Artificial Heart Surgical Training

Invitation-only program at Houston Methodist, one of the top heart transplant centers in the U.S., highlights the growing need for SynCardia Total Artificial Heart technology. Training initiative at Houston Methodist is expected to enable expanded adoption of the SynCardia Total Artificial Heart through further education.

Plasma Resuscitation Early for Evaluating Volume and Endotheliopathy of Thermal Injury (PREEVEnT) trial

PHOENIX (Feb. 23, 2026) – The Diane and Bruce Halle Arizona Burn Center at Valleywise Health is conducting a research study that will look at whether plasma, early in the course of treatment would help severely burned patients survive their injuries.